Stem cells: Hope and hype

About this episode

<p>Lesley Curwen reports on the magical aura that has been drawing so many people around the world to pay for “regenerative” therapies which harness the healing power of stem cells. In this programme, she reports on the battle of regulators in the USA and in Australia to stop unproven and risky therapies harming patients.</p><p>Featuring: Texas lawyer Hartley Hampton; Galen Dinning; stem cell researcher and host of The Niche blog, Professor Paul Knoepfler from the University of California, Davis School of Medicine; Dr Sean Morrison, Professor of Paediatrics at the University of Texas South Western and former president of the global body representing stem cell researchers the ISSCR; Laura Beil, host of the Wondery podcast, Bad Batch; Peter Marks of the Food and Drug Administration, the FDA; Professor Megan Munsie from Stem Cell Australia and chair of the ISSCR Ethics Committee; Dr Sarah Chan from the University of Edinburgh, Scotland.</p><p>(Picture: Stem cells are undifferentiated cells that can specialized through mitosis to many other cell types of multicellular organisms. Credit: selvanegra/Getty Images)</p>